.jpg)
.jpg)
01 Apr, 2020
Shareholders Reject EpiPen Maker's $98 Million Payout
Mylan Inc. (NASDAQ: MYL) made waves earlier this year by awarding former CEO Robert Coury $98 million despite criticism for increasing the company’s EpiPen by 400 percent over seven years. According to CNNMoney, shareholders of the corpor..
FDA Approves Adamis Pharmaceuticals' EpiPen Competitor
Adamis Pharmaceuticals Corp. (NASDAQ: ADMP) shares jumped more than 60% on Thursday, after the U.S Food and Drug Administration (FDA) approved the Adamis’ Epinephrine injection, a generic version of a Mylan N.V.’s EpiPen, which is a..
@Newsletter
Sign Up for Weekly UpdatesOpt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!
No articles found.
.jpg){kind=small}
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).